Srikanth Radhakrishnan Biography and Net Worth

Chief Science and Technology Officer of Pulmonx

Sri has nearly 20 years of experience in the medical device industry. He joined Pulmonx in 2008 and served as Sr. Director/VP of R&D and Operations prior to being named Chief Technical Officer. He started his medical device career at Medtronic AneuRx/AVE and subsequently held management positions in engineering and operations at Bacchus Vascular (Covidien), Foxhollow, and ev3. Previously, he worked in the engineering consulting and energy sectors. Sri holds a BS in Production Engineering from the University of Bombay and an MS in Industrial Engineering from the University of Alabama.

What is Srikanth Radhakrishnan's net worth?: The estimated net worth of Srikanth Radhakrishnan is at least $626.06 thousand as of September 1st, 2026. Mr. Radhakrishnan owns 316,994 shares of Pulmonx stock worth more than $626,063 as of September 17th. This net worth evaluation does not reflect any other assets that Mr. Radhakrishnan may own. Learn More about Srikanth Radhakrishnan's net worth.
How do I contact Srikanth Radhakrishnan?: The corporate mailing address for Mr. Radhakrishnan and other Pulmonx executives is 700 Chesapeake Drive, Redwood City, CA, 94063. Pulmonx can also be reached via phone at 1-650-364-0400 and via email at [email protected]. Learn More on Srikanth Radhakrishnan's contact information.
Has Srikanth Radhakrishnan been buying or selling shares of Pulmonx?: Within the last three months, Srikanth Radhakrishnan has sold $32,193.70 of Pulmonx stock. Most recently, Srikanth Radhakrishnan sold 14,245 shares of the business's stock in a transaction on Tuesday, September 1st. The shares were sold at an average price of $2.26, for a transaction totalling $32,193.70. Following the completion of the sale, the insider now directly owns 316,994 shares of the company's stock, valued at $716,406.44. Learn More on Srikanth Radhakrishnan's trading history.
Who are Pulmonx's active insiders?: Pulmonx's insider roster includes Richard Ferrari (Director), Daniel Florin (Director), Glendon French, III (CEO), Mehul Joshi (CFO), David Lehman (General Counsel), Srikanth Radhakrishnan (Chief Science and Technology Officer), Geoffrey Rose (Insider), and Derrick Sung (CFO). Learn More on Pulmonx's active insiders.
Are insiders buying or selling shares of Pulmonx?: In the last twelve months, insiders at the sold shares 11 times. They sold a total of 202,010 shares worth more than $357,453.20. The most recent insider tranaction occured on September, 1st when CEO Glendon E. French, III sold 41,882 shares worth more than $94,653.32. Insiders at Pulmonx own 7.5% of the company. Learn More about insider trades at Pulmonx.
Information on this page was last updated on 9/1/2026.

Srikanth Radhakrishnan Insider Trading History at Pulmonx

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
9/1/2026	Sell	14,245	$2.26	$32,193.70	316,994
3/2/2026	Sell	10,483	$1.43	$14,990.69	170,736

Srikanth Radhakrishnan Buying and Selling Activity at Pulmonx

Pulmonx Company Overview

Pulmonx Corporation, a commercial-stage medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. The company offers Zephyr Endobronchial Valve, a solution for the treatment of patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation. It also offers StratX Lung Analysis Platform, a cloud-based quantitative computed tomography analysis service that offers information on emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for the treatment with Zephyr Valves. The company serves emphysema patients in the United States, Europe, the Middle East, Africa, the Asia-Pacific, and internationally. The company was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013. Pulmonx Corporation was incorporated in 1995 and is headquartered in Redwood City, California.

Today's Range

Now: $1.98

$1.97

$2.02

50 Day Range

MA: $1.91

$1.17

$2.50

2 Week Range

Now: $1.98

$1.13

$2.89

Volume

264,019 shs

Average Volume

501,690 shs

Market Capitalization

$85.04 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.34